welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
withdrawn
Exisulind in Preventing Polyps in Patients With Familial Adenomatous Polyposis
study id #: NCT00026468
condition: Colorectal Cancer, Small Intestine Cancer
status: withdrawn
purpose:RATIONALE: Exisulind may be effective in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.
PURPOSE: Randomized phase II/III trial to determine the effectiveness of exisulind in preventing the development and growth of polyps in patients who have familial adenomatous polyposis.
intervention: Drug: exisulind
study details
study contacts
expertly curated content related to this topic
-
Surgical Treatment in Familial Adenomatous PolyposisFamilial adenomatous polyposis (FAP) is ...
-
Ileal Pouch and Related Complications: Spectrum of Imaging Findings with Emphasis on MRIProctocolectomy with ileal pouch-anal an...
-
Familial Polyposis and Lynch Syndrome Review March 2014http://www.slideshare.net/douglasriegert...
-
Non-Surgical Management of Attenuated and Deleterious (Classical) Familial Adenomatous Polyposis: A Long-term Survei...The primary objective of this chart revi...
-
Desmoid Tumour in Familial Adenomatous Polyposis Patients: Responses to TreatmentsNo guidelines for desmoid tumors (DT) ma...
-
Pancreaticoduodenectomy for Advanced Duodenal and Ampullary Adenomatosis in Familial Adenomatous PolyposisBACKGROUND : Patients with familial aden...